Cargando…
ZNF9 Activation of IRES-Mediated Translation of the Human ODC mRNA Is Decreased in Myotonic Dystrophy Type 2
Myotonic dystrophy types 1 and 2 (DM1 and DM2) are forms of muscular dystrophy that share similar clinical and molecular manifestations, such as myotonia, muscle weakness, cardiac anomalies, cataracts, and the presence of defined RNA-containing foci in muscle nuclei. DM2 is caused by an expansion of...
Autores principales: | Sammons, Morgan A., Antons, Amanda K., Bendjennat, Mourad, Udd, Bjarne, Krahe, Ralf, Link, Andrew J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823779/ https://www.ncbi.nlm.nih.gov/pubmed/20174632 http://dx.doi.org/10.1371/journal.pone.0009301 |
Ejemplares similares
-
Consensus-based care recommendations for adults with myotonic dystrophy type 2
por: Schoser, Benedikt, et al.
Publicado: (2019) -
Myotonic dystrophy
por: Patterson, VH
Publicado: (1990) -
Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy
por: Nakamori, Masayuki, et al.
Publicado: (2015) -
Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial
por: Kurkiewicz, Adam, et al.
Publicado: (2020) -
Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)